Rates of autoimmune diseases, including thyroid disorders and multiple sclerosis (MS), are higher among families of patients with pediatric MS compared with unaffected families, new research suggests.

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, discusses the current body of data on treating pediatric multiple sclerosis (MS) ...

Please provide your email address to receive an email when new articles are posted on . The 2-year follow-up also showed similar findings in adults with MS, O’Neill, a pediatric neuroimmunology fellow ...

The Jacobs Neurological Institute at UB has received a $1.8 million, five-year grant from the National Multiple Sclerosis Society to establish at Women and Children's Hospital of Buffalo one of six ...

“For the first time, we have an FDA-approved treatment specifically for children and adolescents with multiple sclerosis,” explains Billy Dunn, M.D., director of the Division of Neurology Products in ...

Pediatric-onset MS requires specialized care due to unique clinical features like cognitive issues and motor impairment. Unstructured transitions from pediatric to adult care lead to treatment delays, ...

Early treatment of pediatric-onset relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is associated with substantially slower disability progression than treatment with ...

Recent research has shed new light on multiple sclerosis (MS) in children, who make up about 3% to 5% of the MS population. At one time, children were thought to not experience disability due to their ...

Please provide your email address to receive an email when new articles are posted on . A “high relative abundance” of a gut microbiota species in the Blautia genus correlated with a greater risk for ...

Demyelinating disease, including multiple sclerosis and neuromyelitis optica, can affect children and teens. Our program works closely with the Multiple Sclerosis Program at University of Utah ...

Children living with multiple sclerosis (MS) show signs of accelerated biological aging, even in their teenage years. This is according to new research from scientists at the University of California ...

While diagnostic criteria for typical multiple sclerosis (MS) perform well in people ages 18 to 50, differential diagnoses in pediatric-onset MS and late-onset MS require specific considerations.